VEGFC Human HEK

Vascular Endothelial Growth Factor C Human Recombinant HEK
Cat. No.
BT8635
Source
HEK293 cells.
Synonyms
VEGF-C, Vascular endothelial growth factor C, VRP, Flt4 ligand, Flt4-L, Vascular endothelial growth factor-related protein, VEGFC.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

VEGFC Human Recombinant produced by transfected human cells is a single polypeptide chain containing 204 amino acids (32-227). VEGFC is fused to an 8 amino acid His-tag at C-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
VEGF-C, alternatively known as Vascular Endothelial Growth Factor Related Protein (VRP), is a recently identified member of the VEGF growth factor family. It shares a close relationship with VEGF-D. The human VEGF-C cDNA encodes a precursor protein consisting of 416 amino acids, demonstrating near-identicality to its murine counterpart. Similar to VEGF-D, VEGF-C possesses a VEGF homology domain located within the central third of the precursor molecule, flanked by extended N- and C-terminal regions. In adult tissues, VEGF-C exhibits high expression levels in the heart, placenta, ovary, and small intestine. When the N- and C-terminal extensions are absent, recombinant human VEGF-C, encompassing solely the central VEGF homology domain, predominantly forms non-covalently linked dimers. This protein interacts with both VEGFR-2/KDR and VEGFR-3/FLT-4 receptors. The prominent expression of VEGFR-3 in lymphatic endothelial cells suggests a role for VEGF-C in regulating lymphatic endothelium growth and/or differentiation. Although recombinant human VEGF-C demonstrates mitogenic activity in vascular endothelial cells, its potency is notably lower compared to VEGF-A.
Description
Recombinant Human VEGFC, produced in transfected human cells, is a single polypeptide chain comprising 204 amino acids (residues 32-227). The protein includes an 8 amino acid His-tag fused at the C-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
White, lyophilized (freeze-dried) powder, sterile-filtered.
Formulation
VEGFC was lyophilized from a 0.2 µM filtered solution containing 20mM Tris-HCl and 150mM NaCl at pH 7.2.
Solubility
For reconstitution, it is recommended to dissolve the lyophilized VEGFC in 1xPBS to achieve a concentration of at least 100 µg/ml. This solution can be further diluted into other aqueous solutions as needed.
Stability
Lyophilized VEGFC remains stable at room temperature for up to 3 weeks; however, it is recommended to store it desiccated at a temperature below -18°C. After reconstitution, VEGFC can be stored at 4°C for 2-7 days. For long-term storage, it should be kept at -18°C. Repeated freeze-thaw cycles should be avoided.
Purity
The purity is determined to be greater than 95% as assessed by SDS-PAGE analysis.
Synonyms
VEGF-C, Vascular endothelial growth factor C, VRP, Flt4 ligand, Flt4-L, Vascular endothelial growth factor-related protein, VEGFC.
Source
HEK293 cells.
Amino Acid Sequence
FESGLDLSDAEPDAGEATAYASKDLEEQLRSVSSVDELMTVLYPEYWKMYK
CQLRKGGWQHNREQANLNSRTEETIKFAAAHYNTEILKSIDNEWRKTQCMP
REVCIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGQCMNTSTSYLSKTLF
EITVPLSQGPKPVTISFANHTSCRCMSKLDVYRQVHSIIRRVDHHHHHH.

Product Science Overview

Introduction

Vascular Endothelial Growth Factor C (VEGF-C) is a member of the VEGF/PDGF family of structurally related proteins. It is a potent angiogenic cytokine that plays a crucial role in promoting endothelial cell growth, lymphangiogenesis, and vascular permeability .

Structure and Expression

VEGF-C is a disulfide-linked homodimeric protein consisting of two 116 amino acid polypeptide chains. Due to glycosylation, the protein migrates as a 30.0-33.0 kDa band by SDS-PAGE analysis under non-reducing conditions . The human recombinant form of VEGF-C is expressed in HEK 293 cells, which are human embryonic kidney cells commonly used in biological research .

Biological Functions

VEGF-C binds and activates both VEGFR-2 (flk1) and VEGFR-3 (flt4) receptors. During embryogenesis, VEGF-C plays a significant role in the formation of the venous and lymphatic vascular systems . It is also involved in promoting lymphangiogenesis, which is the formation of lymphatic vessels from pre-existing lymphatic vessels .

Clinical Significance

VEGF-C is over-expressed in certain cancers, and elevated levels of VEGF-C tend to correlate with increased lymphatic metastasis . This makes VEGF-C a potential target for therapeutic interventions in cancer treatment. Additionally, VEGF-C is not produced in peripheral blood lymphocytes, which suggests its specific expression in certain tissues .

Applications

Recombinant human VEGF-C is used in various research applications, including cell culture studies to investigate its effects on endothelial cells and lymphangiogenesis . It is also utilized in studies related to cancer research and therapeutic development .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.